REAX · The Real Brokerage, Inc. · Stock research

Current Thesis

The narrative that carried REAX — a cloud-native, agent-first brokerage compounding revenue 70%+ a year — has visibly matured. Q1 2026 (reported 2026-05-07) put revenue at $465.6M, up 32% YoY from $354.0M, and it still came in light of consensus. Agent count of 33,510 grew 25% YoY, later surpassing 35,000 on 2026-06-24. Both lines are still growing, but the second derivative has rolled over, and the market has repriced accordingly: the stock closed $2.18 on 2026-07-16, roughly 47% lower YTD and about 60% below its 52-week high of $5.38 (August 2025).

Layered on top is a company-remaking event — the 2026-04-27 agreement to acquire RE/MAX Holdings for ~$880M. That converts REAX from a clean secular-growth long into a special situation: the tradeable question is no longer "how fast does organic growth compound" but "does an $880M cash-and-stock deal for a shrinking legacy franchise close, integrate, and hit its $30M synergy target." Price structure is broken and near lows; this is a falling-knife-with-a-catalyst, not an accelerating momentum setup. Stand aside on fresh entries until it either bases and reclaims structure or the deal closes clean.

Bullish and bearish views on The Real Brokerage, Inc.

The model's bull view on The Real Brokerage, Inc. (REAX), in brief: Scale leadership at a distressed price. Surpassed 35,000 agents on 2026-06-24 (top-5 brokerage in North America by agents/volume), adding 3,200+ in H1 2026 and 15,000+ since the start of 2024. That growth continued even as the multiple collapsed. The RE/MAX deal builds a… The bear view: Deceleration is the story. Revenue growth of +32% (Q1 2026) versus the 70%+ prints of prior years, plus a consensus miss, is what a maturing hyper-growth name looks like right before the multiple resets — which it did. The deal spooked the tape. Shares fell ~25% around the… Both cases follow in full.

Bull Case

• Scale leadership at a distressed price. Surpassed 35,000 agents on 2026-06-24 (top-5 brokerage in North America by agents/volume), adding 3,200+ in H1 2026 and 15,000+ since the start of 2024. That growth continued even as the multiple collapsed.
• The RE/MAX deal builds a 180,000-agent global platform. Pro forma 2025 basis (announced 2026-04-27): ~$2.3B revenue and ~$157M adjusted EBITDA, struck at 7x 2025 EBITDA with ~$30M targeted synergies. If it closes and integrates, REAX steps from disruptor to consolidator of a fragmented industry.
• Profitability inflecting. Q1 2026 adjusted EBITDA of $14.9M nearly doubled the $8.3M a year prior; net loss narrowed to $(3.4)M from $(5.0)M. Ancillaries (mortgage, title attach) are a modest, growing gross-margin tailwind.
• Analysts see a gap to close. Consensus sits at Strong Buy with an average target near $5.15 (range ~$4–$7); That is a wide bull/bear spread on a beaten-down name.

Bear Case

• Deceleration is the story. Revenue growth of +32% (Q1 2026) versus the 70%+ prints of prior years, plus a consensus miss, is what a maturing hyper-growth name looks like right before the multiple resets — which it did.
• The deal spooked the tape. Shares fell ~25% around the 2026-04-27 announcement and broke from the $2.60s into the low $2s (intraday low $1.96) on dilution and integration fears. RE/MAX's North American agent base has been in multi-year decline; buying a shrinking franchise to bolt onto a decelerating one is not obviously accretive to the growth narrative.
• Housing backdrop is a headwind, not a tailwind. Frozen existing-home transaction volume and elevated mortgage rates cap the revenue-per-agent lever. BTIG explicitly cut its target citing a tougher 2026 housing environment.
• Still GAAP-unprofitable with binary overhangs. The company remains net-loss-making; the merger needs shareholder and regulatory approval to close in H2 2026, and Q2 opex will step up on non-recurring deal costs. Cheap-looking multiple + rolled-over chart is the classic value-trap configuration.

Setup & Price Structure

Downtrend, not a base. The 2026-07-16 close of $2.18 sits below every meaningful moving average, near the 52-week low of $1.96 and far under the $5.38 high from August 2025. The name gapped down through the $2.60s shelf on the deal and has churned in the low $2s since. The early-July pop (~+9.6% on the 35,000-agent milestone) was a relief bounce inside a broken structure, not a trend change. This is the opposite of the stretched-above-MA, peak-retail-sentiment trap — the risk here is the mirror image: buying weakness into a downtrend and rationalizing it as "cheap." First evidence of a real turn would be reclaiming the ~$2.60 pre-deal shelf on volume; absent that, dips are suspect. Earnings on 2026-08-06 is ~19 days out, so the near-term risk is a binary print, not an immediate blackout.

Catalyst Calendar (next 30 days)

• Ongoing (through H2 2026) — RE/MAX merger approval track. Shareholder-vote scheduling and regulatory (antitrust) clearance milestones are the swing factor above any single quarter; each procedural update moves the deal spread. No confirmed date inside 30 days, but headline risk is live.

Elapsed catalysts

• 2026-08-06 (before open) — Q2 2026 earnings + call (8:00am ET). Consensus revenue ~$667M (seasonal Q2 peak) and EPS ~$0.01. Guidance color flags sequential revenue growth, near-term gross-margin pressure as more agents hit commission caps, and a non-recurring Q2 opex step-up tied to RE/MAX deal activity. This is the dominant dated event inside the window. (passed 3d ago)
• Monthly — agent-count updates. Management has been publishing milestone releases (last: 35,000 on 2026-06-24); the next round-number update is a sentiment marker, not a fundamental one. (passed 46d ago)

What Would Change Our Mind

Constructive re-rate: a decisive reclaim of the ~$2.60 broken shelf on expanding volume, a Q2 print on 2026-08-06 that shows revenue growth stabilizing rather than decelerating further, and concrete progress toward merger approval with a firm close date — that combination flips this from a special-situation avoid into a momentum-eligible long. Thesis-break condition: a weekly close below $1.95 confirms the downtrend and voids the basing case; a merger being voted down or blocked by regulators would remove the consolidation optionality entirely and reset the name to standalone-decelerating fundamentals. A close back above the 200-day and a housing-transaction-volume upturn would be the earliest cross-checks that the tape is turning.

Correlation Notes

REAX trades with the rate-sensitive housing/proptech complex — direct cloud-brokerage comp eXp World Holdings (EXPI), plus Compass (COMP), Zillow (Z/ZG), and Opendoor (OPEN) — all levered to the 10-year yield, mortgage rates, and existing-home transaction volume; a dovish rate impulse lifts the whole basket. Post-announcement, REAX is also mechanically tied to RE/MAX (RMAX), which now tracks the merger terms (5.152 shares or $13.80 cash), so deal-spread moves couple the two tickers until close. Idiosyncratic risk dominates near term: the merger vote and regulatory clearance will drive REAX independently of the housing tape.